AstraZeneca has promoted Maciej Szymaszek, PhD, MBA, PMP, to Head of Commercial AI Strategy, Innovation and Business Operations, expanding his leadership role within the company’s Enterprise AI unit.
He said “I’m very grateful for the partnerships we have built across our business units. I’m thrilled to begin this next chapter, playing to win with fantastic people and turning the possibilities of AI into meaningful business impact.”
About Maciej Szymaszek
Szymaszek has been with AstraZeneca for more than seven years, joining in 2019 as Associate Director of Global Project Management and advancing through roles in portfolio management, business transformation, and strategy. Most recently, as Head of Strategy & Innovation for Commercial AI, he led the global scale-up of AI productivity tools and agentic platforms to more than 45,000 commercial colleagues.
Szymaszek also served as business lead for the company’s enterprise AI Accelerator and its award-winning “Thriving in the Age of AI” upskilling program, which has issued more than 200,000 certificates since its 2025 launch.
Szymaszek holds a PhD from the Catholic University of Lublin and the University of Gothenburg, and an MBA from Imperial College London.
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including cardiovascular, renal and metabolic, and respiratory and immunology therapies. Based in Cambridge, UK, its medicines are sold in more than 125 countries and used by millions of patients worldwide.
